Skip to Main Content

Author Details

Barbara J Mann
University of Virginia
1985
109
38
Sarah J Ratcliffe (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36821695Inhibition of the mitochondrial pyruvate carrier simultaneously mitigates hyperinflammation and hyperglycemia in COVID-19.Sci Immunol2023
35386716Trajectory of IgG to SARS-CoV-2 After Vaccination With BNT162b2 or mRNA-1273 in an Employee Cohort and Comparison With Natural Infection.Front Immunol2022
34185704IL-13 is a driver of COVID-19 severity.JCI Insight2021
33688686IL-13 is a driver of COVID-19 severity.medRxiv2021
34795290Development of COVID-19 vaccine using a dual Toll-like receptor ligand liposome adjuvant.NPJ Vaccines2021
32241221Characterization of Schu S4 <i>aro</i> mutants as live attenuated tularemia vaccine candidates.Virulence2020
32723427Evaluation of K18-<i>hACE2</i> Mice as a Model of SARS-CoV-2 Infection.Am J Trop Med Hyg2020
30220581Kinesin-5 Regulation and Function in Mitosis.Trends Cell Biol2019
29109188Zinc Acquisition Mechanisms Differ between Environmental and Virulent Francisella Species.J Bacteriol2018
30123975Distribution of Eg5 and TPX2 in mitosis: Insight from CRISPR tagged cells.Cytoskeleton (Hoboken)2018
30346998Aerosol prime-boost vaccination provides strong protection in outbred rabbits against virulent type A Francisella tularensis.PLoS One2018
27852894Regulation of Kif15 localization and motility by the C-terminus of TPX2 and microtubule dynamics.Mol Biol Cell2017
28077440Monophosphoryl Lipid A Enhances Efficacy of a Francisella tularensis LVS-Catanionic Nanoparticle Subunit Vaccine against F. tularensis Schu S4 Challenge by Augmenting both Humoral and Cellular Immunity.Clin Vaccine Immunol2017
28646493Src family kinase phosphorylation of the motor domain of the human kinesin-5, Eg5.Cytoskeleton (Hoboken)2017
28739786Benzoxazoles, Phthalazinones, and Arylurea-Based Compounds with IMP Dehydrogenase-Independent Antibacterial Activity against Francisella tularensis.Antimicrob Agents Chemother2017
26869224Suppression of microtubule assembly kinetics by the mitotic protein TPX2.J Cell Sci2016
27193839Using Fluorescence Microscopy to Study Mitosis.Methods Mol Biol2016
27028889Components of the type six secretion system are substrates of Francisella tularensis Schu S4 DsbA-like FipB protein.Virulence2016
25986219Characterization of Francisella tularensis Schu S4 defined mutants as live-attenuated vaccine candidates.Pathog Dis2015
26553462Escherichia coli Pyruvate Dehydrogenase Complex Is an Important Component of CXCL10-Mediated Antimicrobial Activity.Infect Immun2015
26018074TPX2 Inhibits Eg5 by Interactions with Both Motor and Microtubule.J Biol Chem2015
24351755Novel catanionic surfactant vesicle vaccines protect against Francisella tularensis LVS and confer significant partial protection against F. tularensis Schu S4 strain.Clin Vaccine Immunol2014
25092026FipB, an essential virulence factor of Francisella tularensis subsp. tularensis, has dual roles in disulfide bond formation.J Bacteriol2014
25147601Repurposing cryptosporidium inosine 5'-monophosphate dehydrogenase inhibitors as potential antibacterial agents.ACS Med Chem Lett2014
24614653Live attenuated mutants of Francisella tularensis protect rabbits against aerosol challenge with a virulent type A strain.Infect Immun2014
24285623Eg5 restricts anaphase B spindle elongation in mammalian cells.Cytoskeleton (Hoboken)2014
23921460Adherence and uptake of Francisella into host cells.Virulence2013
23840797Structure-Function Analysis of DipA, a Francisella tularensis Virulence Factor Required for Intracellular Replication.PLoS One2013
21750122Role of TLR signaling in Francisella tularensis-LPS-induced, antibody-mediated protection against Francisella tularensis challenge.J Leukoc Biol2011
21931773Requirement of the CXXC motif of novel Francisella infectivity potentiator protein B FipB, and FipA in virulence of F. tularensis subsp. tularensis.PLoS One2011
21605655Impact of Francisella tularensis pilin homologs on pilus formation and virulence.Microb Pathog2011
20416090Azithromycin effectiveness against intracellular infections of Francisella.BMC Microbiol2010
20689746Regulation of Virulence of Entamoeba histolytica by the URE3-BP Transcription Factor.mBio2010
18981253Identification of an essential Francisella tularensis subsp. tularensis virulence factor.Infect Immun2009
19538114Rationally designed tularemia vaccines.Expert Rev Vaccines2009
18822389Development of the Gateway system for cloning and expressing genes in Entamoeba histolytica.Parasitol Int2009
18658254Characterization of an Entamoeba histolytica high-mobility-group box protein induced during intestinal infection.Eukaryot Cell2008
18846235Targets of the Entamoeba histolytica transcription factor URE3-BP.PLoS Negl Trop Dis2008
18458069Francisella tularensis subsp. tularensis Schu S4 disulfide bond formation protein B, but not an RND-type efflux pump, is required for virulence.Infect Immun2008
18063096Structure and content of the Entamoeba histolytica genome.Adv Parasitol2007
16290089Kinetics and strain variation of phagosome proteins of Entamoeba histolytica by proteomic analysis.Mol Biochem Parasitol2006
16879747Identification of transposon insertion mutants of Francisella tularensis tularensis strain Schu S4 deficient in intracellular replication in the hepatic cell line HepG2.BMC Microbiol2006
16569449Impact of intestinal colonization and invasion on the Entamoeba histolytica transcriptome.Mol Biochem Parasitol2006
15729342The genome of the protist parasite Entamoeba histolytica.Nature2005
15821141Proteomic analysis of phagocytosis in the enteric protozoan parasite Entamoeba histolytica.Eukaryot Cell2005
15955316Proteomic analysis of Gal/GalNAc lectin-associated proteins in Entamoeba histolytica.Exp Parasitol2005
14630697Regulation of Toll-like receptor-2 expression by the Gal-lectin of Entamoeba histolytica.FASEB J2004
15555732Histone acetyltransferases and deacetylase in Entamoeba histolytica.Mol Biochem Parasitol2004
12466263Calcium modulates promoter occupancy by the Entamoeba histolytica Ca2+-binding transcription factor URE3-BP.J Biol Chem2003
14723357Characterization of Leishmania chagasi DNA topoisomerase II: a potential chemotherapeutic target.Scand J Infect Dis2003
  • 1 - 50 of 109

Recommended Authors

CSIR - National Chemical Laboratory
Career Start Year 2008
Number of shared co-authors 1
Indiana University School of Medicine
Career Start Year 2007
Number of shared co-authors 0
University of California - San Francisco
Career Start Year 2007
Number of shared co-authors 0
University of Geneva
Career Start Year 2005
Number of shared co-authors 0
Lankenau Institute for Medical Research
Career Start Year 2004
Number of shared co-authors 0
University of Nebraska at Omaha
Career Start Year 2003
Number of shared co-authors 0
Temple University
Career Start Year 2002
Number of shared co-authors 0
The University of Texas at Austin
Career Start Year 2000
Number of shared co-authors 0
University of Toronto, University Avenue
Career Start Year 2000
Number of shared co-authors 0
King Abdullah University of Science and Technology
Career Start Year 1997
Number of shared co-authors 5
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1996
Number of shared co-authors 0
Texas A&M University, College Station
Career Start Year 1995
Number of shared co-authors 0
Huck Institutes of Life Sciences, The Pennsylvania State University, University Park
Career Start Year 1992
Number of shared co-authors 2
University of Washington School of Medicine
Career Start Year 1987
Number of shared co-authors 6
Seattle Structural Genomics Center for Infectious Disease (SSGCID)
Career Start Year 1986
Number of shared co-authors 0
University of California
Career Start Year 1986
Number of shared co-authors 1
Texas A&M University
Career Start Year 1983
Number of shared co-authors 1
and the California NanoSystems Institute, University of California los angeles
Career Start Year 1983
Number of shared co-authors 0
Johns Hopkins Bloomberg School of Public Health
Career Start Year 1982
Number of shared co-authors 1
Center for Emerging and Re-emerging Infectious Diseases, University of Washington
Career Start Year 1982
Number of shared co-authors 2
Icahn School of Medicine at Mount Sinai
Career Start Year 1981
Number of shared co-authors 0
University of Guelph
Career Start Year 1981
Number of shared co-authors 5
Public Health Research Institute, Rutgers New Jersey Medical School
Career Start Year 1980
Number of shared co-authors 0
Texas A&M University, College Station
Career Start Year 1979
Number of shared co-authors 0
Max Planck Institute for Infection Biology
Career Start Year 1979
Number of shared co-authors 0
The Genome Center at Washington University, Washington University School of Medicine
Career Start Year 1979
Number of shared co-authors 5
Duke University
Career Start Year 1978
Number of shared co-authors 0
University of California san francisco
Career Start Year 1977
Number of shared co-authors 1
Nursing and Health SciencesMonash UniversityClaytonVictoriaAustralia.
Career Start Year 1975
Number of shared co-authors 0
Sandler Center for Drug Discovery, University of California San Francisco
Career Start Year 1970
Number of shared co-authors 1

Collaborators

University of Virginia
Co-authored papers 46
University of Virginia
Co-authored papers 7
University of Virginia
Co-authored papers 5
University of Virginia School of Medicine
Co-authored papers 5
University of California los angeles
Co-authored papers 4
University of Virginia School of Medicine
Co-authored papers 3
University of Virginia Health System. Charlottesville
Co-authored papers 3
Co-authored papers 3
University of British Columbia
Co-authored papers 3
University of Virginiagrid.412587.dgrid.27755.32 School of Medicine
Co-authored papers 2
Co-authored papers 2
University of Virginia
Co-authored papers 2
Charite-Universitatsmedizin Berlin
Co-authored papers 2
University of Virginia
Co-authored papers 2
Lydia Becker Institute for Immunology & Infection, University of Manchester
Co-authored papers 2
Institute for Physiology, Charite-University Medicine Berlin
Co-authored papers 2
University of Virginia
Co-authored papers 2
Virginia Commonwealth University.
Co-authored papers 2
Lydia Becker Institute for Immunology & Infection, University of Manchester
Co-authored papers 2
Earlham Institute
Co-authored papers 2
University of Virginia School of Medicine
Co-authored papers 2
Virginia Commonwealth University.
Co-authored papers 2
University of Virginia School of Medicine
Co-authored papers 2
university of california san diego Health
Co-authored papers 2
University of Virginia
Co-authored papers 2
University of Washington
Co-authored papers 2
Integrated Translational Health Research Institute of Virginia (iTHRIV)
Co-authored papers 2
Children's Hospital of Richmond at Virginia Commonwealth University
Co-authored papers 2
University of Virginia
Co-authored papers 1
Co-authored papers 1